Podrobno

Globalni vpliv pandemije COVID-19 na avtomobilistično panogo in prilagoditve v Sloveniji : magistrsko delo
ID Tejić, Dejan (Avtor), ID Čadež, Simon (Mentor) Več o mentorju... Povezava se odpre v novem oknu

URLURL - Predstavitvena datoteka, za dostop obiščite http://www.cek.ef.uni-lj.si/magister/tejic4641-B.pdf Povezava se odpre v novem oknu

Jezik:Slovenski jezik
Ključne besede:Slovenija, pandemija, Covid-19, avtomobilska industrija, prodaja, analiza, komparacije, usklajevanje
Vrsta gradiva:Magistrsko delo/naloga
Tipologija:2.09 - Magistrsko delo
Organizacija:EF - Ekonomska fakulteta
Kraj izida:Ljubljana
Založnik:[D. Tejić]
Leto izida:2022
Št. strani:III, 70, 11 str.
PID:20.500.12556/RUL-139293 Povezava se odpre v novem oknu
UDK:338.4
COBISS.SI-ID:117036291 Povezava se odpre v novem oknu
Datum objave v RUL:01.11.2022
Število ogledov:1175
Število prenosov:69
Metapodatki:XML DC-XML DC-RDF
:
TEJIĆ, Dejan, 2022, Globalni vpliv pandemije COVID-19 na avtomobilistično panogo in prilagoditve v Sloveniji : magistrsko delo [na spletu]. Magistrsko delo. Ljubljana : D. Tejić. [Dostopano 1 april 2025]. Pridobljeno s: http://www.cek.ef.uni-lj.si/magister/tejic4641-B.pdf
Kopiraj citat
Objavi na:Bookmark and Share

Sekundarni jezik

Jezik:Angleški jezik
Naslov:Global impact of the COVID-19 pandemic on the automotive industry and adjustments in Slovenia
Ključne besede:Slovenia, pandemic, Covid-19 car industry, sales, analysis, comparisons, adjustment

Podobna dela

Podobna dela v RUL:
  1. Systematic review and meta-analysis of observational studies evaluating treatment outcomes in patients with metastatic non-small-cell lung cancer on first-line immune checkpoint inhibitors therapy
  2. Description of adverse event of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer treated at the University Clinic Golnik
  3. Effectivness and safety of immunotherapy in patients with advanced non-small cell lung cancer in second line treatment at the University Clinic Golnik
  4. Evaluation of possible pembrolizumab dosing regimen racionalisation in advanced non-small cell lung cancer
  5. ǂThe ǂpotential of immunotherapies in the treatment of lung cancer
Podobna dela v drugih slovenskih zbirkah:
  1. ǂThe ǂrole of immune checkpoint inhibitors in the treatment of cancer of unknown origin
  2. Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA)
  3. Febrile neutropenia and grade 3/4 neutropenia in daily practice of adjuvant chemotherapy for non-small-cell lung cancer
  4. Advances in the therapy with immune-check point inhibitors (ICI) in non-small cell lung cancer (NSCLC) in 2022
  5. Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy

Nazaj